Literature DB >> 16188838

Dysmetabolic syndrome in childhood and adolescence.

Maria Bitsori1, Anthony Kafatos.   

Abstract

UNLABELLED: The dysmetabolic syndrome, consisting of dyslipidaemia, hypertension, hyperinsulinaemia and central obesity, has been well recognized as a major risk for cardiovascular disease in adults. Although the clustering of cardiovascular risk factors has also been identified in childhood, the occurrence of full-blown dysmetabolic syndrome at younger ages has only recently been investigated. In this article we attempted an overview of the data for children and adolescents, focused on the mechanisms and natural history of the disease, the prevalence among paediatric populations, the assessment and the treatment approaches.
CONCLUSION: There is substantial evidence that the dysmetabolic syndrome has its origins in childhood. In the face of the epidemic increase of obesity in children and adolescents, the development of effective screening and preventive strategies would be a major challenge for paediatricians.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16188838     DOI: 10.1111/j.1651-2227.2005.tb02034.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  11 in total

1.  Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese.

Authors:  A Galli-Tsinopoulou; M G Grammatikopoulou; C Stylianou; E Emmanouilidou; P Kokka
Journal:  J Endocrinol Invest       Date:  2010-02-24       Impact factor: 4.256

2.  Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children?

Authors:  Jun-Fen Fu; Hong-Bo Shi; Li-Rui Liu; Ping Jiang; Li Liang; Chun-Lin Wang; Xi-Yong Liu
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

3.  Distributions of waist circumference and waist-to-height ratio for children and adolescents in Shandong, China.

Authors:  Zhang Ying-Xiu; Li Ya-Lin; Zhao Jin-Shan; Chu Zun-Hua; Zhou Jing-Yang
Journal:  Eur J Pediatr       Date:  2012-10-14       Impact factor: 3.183

4.  Diversity of metabolic syndrome risk factors in obese children and adolescents.

Authors:  G Bueno; O Bueno; L A Moreno; R García; B Tresaco; J M Garagorri; M Bueno
Journal:  J Physiol Biochem       Date:  2006-06       Impact factor: 5.080

5.  The influence of the Korean traditional Chungkookjang on variables of metabolic syndrome in overweight/obese subjects: study protocol.

Authors:  Hyang-Im Back; Ki-Chan Ha; Hye-Mi Kim; Min-Gul Kim; Ok-Kyeong Yu; Moon-Sun Byun; Do-Youn Jeong; Seong-Yeop Jeong; Youn-Soo Cha; Tae-Sun Park
Journal:  BMC Complement Altern Med       Date:  2013-10-31       Impact factor: 3.659

6.  Metabolic syndrome and its components among university students in Kenya.

Authors:  Samuel Mungai Mbugua; Samuel Thuo Kimani; Gilbert Munyoki
Journal:  BMC Public Health       Date:  2017-11-28       Impact factor: 3.295

7.  Prevalence of metabolic syndrome in adolescents aged 10-18 years in Jammu, J and K.

Authors:  Narinder Singh; Ravi Kumar Parihar; Ghanshyam Saini; Sandeep Kumar Mohan; Neeraj Sharma; Mohd Razaq
Journal:  Indian J Endocrinol Metab       Date:  2013-01

8.  Metabolic risk-factor clustering estimation in obese children.

Authors:  G Bueno; L A Moreno; O Bueno; J Morales; T Pérez-Roche; J M Garagorri; M Bueno
Journal:  J Physiol Biochem       Date:  2007-12       Impact factor: 5.080

9.  Prevalence of the metabolic syndrome among obese adolescents enrolled in a multidisciplinary weight management program: clinical correlates and response to treatment.

Authors:  Edmond P Wickham; Marilyn Stern; Ronald K Evans; Daphne L Bryan; William B Moskowitz; John N Clore; Joseph H Laver
Journal:  Metab Syndr Relat Disord       Date:  2009-06       Impact factor: 2.363

10.  The prevalence of the metabolic syndrome in Korean children and adolescents: comparisons of the criteria of Cook et al., Cruz and Goran, and ferranti et al.

Authors:  Su Jin Seo; Hyo Young Lee; Seung Wook Lee
Journal:  Yonsei Med J       Date:  2008-08-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.